A

    Aveanna Healthcare Holdings Inc (AVAH)

    Official site

    HEALTHCARE • MEDICAL CARE FACILITIES • NASDAQ

    $13.32
    -0.50 (-3.62%)

    Market Cap: $2.91B

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    68%(15/22)
    Avg Surprise
    +665.16%
    Streak
    11 Q

    Upcoming Estimates

    Sep 30, 2026
    EPS Consensus$0.21
    Range$0.19 - $0.23
    8 analysts
    EPS Revisions
    3
    0
    7d
    3
    0
    30d
    EPS Estimate Drift
    90d ago$0.16-21.8%
    60d ago$0.17-18.7%
    30d ago$0.17-17.1%
    7d ago$0.20-2.8%
    Current$0.21
    Revenue Consensus
    $679M
    Range$667M - $692M
    9 analysts
    Dec 31, 2026
    EPS Consensus$0.32
    Range$0.29 - $0.36
    9 analysts
    Revenue Consensus
    $758M
    Range$714M - $785M
    10 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$0.32---
    Sep 26EST
    		-$0.21---
    Jun 26
    		$0.21$0.16+31.25%Beat+31.2%
    Mar 26
    		$0.18$0.13+38.46%Beat+80.0%
    Dec 25
    		$0.17$0.13+28.89%Beat+240.0%
    Sep 25
    		$0.15$0.13+15.38%Beat+650.0%
    Jun 25
    		$0.16$0.01+1500.00%Beat+1500.0%
    Mar 25
    		$0.10$-0.00+2731.58%Beat+433.3%
    Dec 24
    		$0.05$-0.00+10100.00%Beat+350.0%
    Sep 24
    		$0.02$-0.01+300.00%Beat+166.7%
    Jun 24
    		$0.01$-0.02+150.00%Beat+150.0%
    Mar 24
    		$-0.03$-0.05+40.00%Beat+40.0%
    Dec 23
    		$-0.02$-0.02+0.00%Beat+33.3%
    Sep 23
    		$-0.03$-0.02-50.00%Miss+0.0%
    Jun 23
    		$-0.02$-0.04+50.00%Beat-166.7%
    Mar 23
    		$-0.05$-0.06+16.67%Beat-225.0%
    Dec 22
    		$-0.03$-0.02-50.00%Miss-130.0%
    Sep 22
    		$-0.03$0.04-175.00%Miss-127.3%
    Jun 22
    		$0.03N/A-57.14%Miss-70.0%
    Mar 22
    		$0.04$0.06-33.33%Miss-50.0%
    Dec 21
    		$0.10$0.11-9.09%Miss+15.6%
    Sep 21
    		$0.11$0.12-8.33%Miss-
    Jun 21
    		$0.10$0.10+0.00%Beat-
    Mar 21
    		$0.08$0.07+14.29%Beat-
    Dec 20
    		$0.09$0.00N/ABeat-

    Key Metrics

    Valuation
    P/E Ratio18.76EV/EBITDA14.56x
    Price/FCF19.34xFCF Yield5.17%
    Profitability
    Profit Margin10.60%Operating Margin12.60%
    ROE198.60%ROIC57.84%
    Financial Health
    Debt/Equity0.68xInterest Coverage2.24x
    Current Ratio1.16xQuick Ratio1.16x
    Trading Statistics
    Beta1.93Avg Volume3.47M
    52-Week High$14.0052-Week Low$5.93

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$13.27
    SMA 20$11.54
    SMA 50$10.16
    SMA 200$8.30
    EMA 10$12.98
    EMA 20$12.04
    EMA 50$10.47
    EMA 200$8.44

    MACD

    Line: 1.15Signal: 1.00Hist: 0.15

    ADX

    ADX: 38.6+DI: 33.4-DI: 13.6

    Aroon & PSAR

    Aroon Up96.0
    Aroon Down52.0
    PSAR$12.41

    Bollinger Bands

    Upper Band$15.43
    Lower Band$7.65
    %B Position6741%(Upper)
    Band Width0.73

    RSI (14-Day)

    Overbought
    71.2

    Momentum Oscillators

    Stoch %K92.2
    Stoch %D93.2
    Williams %R-13.0
    ROC (10d)8.1%
    Momentum1.00
    CCI (20d)74.2
    MFI (14d)69.8

    Volatility Measures

    ATR (14d)$0.60(4.5%)
    StdDev (20d)1.95
    Hist Vol98.3%(High)

    Volume Flow

    VWAP$13.50
    OBV88.8M
    AD Line41.7M
    CMF (20d)0.287

    Volume Metrics

    Avg Vol (20d)3.7M
    Vol Ratio0.6x
    VWMA (20d)$12.02

    Pivot Points

    R3$14.52
    R2$14.26
    R1$14.04
    Pivot Point$13.78
    S1$13.56
    S2$13.30
    S3$13.08

    Advanced Oscillators

    TSI51.85
    Ultimate Osc54.0
    KST352.29

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$670.48M$647.91M$662.48M$621.94M$589.55M$559.22M$519.87M$509.02M$504.96M$490.65M$478.84M$478.01M
    Cost of Revenue$451.96M$445.53M$451.91M$421.72M$378.75M$375.67M$348.15M$349.32M$346.69M$344.80M$330.39M$330.75M
    Gross Profit$218.53M$202.38M$210.57M$200.22M$210.80M$183.56M$171.72M$159.70M$158.27M$145.85M$148.45M$147.26M
    Operating Expenses$138.54M$126.44M$133.30M$143.95M$130.77M$131.76M$125.95M$125.67M$121.14M$122.99M$119.16M$223.62M
    R&D$0$0$0$0$0$0$0$0$0$0$0$0
    SG&A$0$129.55M$132.17M$143.53M$122.53M$128.50M$119.92M$118.08M$116.36M$117.18M$107.25M$117.97M
    Operating Income$79.98M$75.94M$77.27M$56.27M$80.03M$51.80M$45.77M$34.02M$37.13M$22.87M$29.29M$-76,352,000
    Interest Income$0$1.66M$1.74M$826,000$129,000$132,000$201,000$100,000$95,000$102,000$89,000$50,000
    Interest Expense$27.78M$29.16M$32.62M$35.13M$36.00M$36.34M$38.10M$39.24M$39.61M$39.65M$39.70M$39.60M
    Income Before Tax$56.47M$44.98M$39.24M$13.42M$44.14M$10.15M$26.93M$-27,332,000$3.98M$1.49M$-31,595,000$-101,758,000
    Income Tax Expense$16.18M$3.32M$-139,507,000$-647,000$17.11M$4.96M$-2,245,000$15.51M$-9,927,000$12.66M$-5,859,000$631,000
    Net Income$40.29M$41.65M$178.75M$14.06M$27.02M$5.19M$29.18M$-42,843,000$13.91M$-11,172,000$-25,736,000$-102,389,000
    EBITDA$87.10M$81.78M$74.59M$55.67M$87.11M$51.78M$70.57M$19.26M$51.06M$49.06M$14.03M$-54,881,000
    EBIT$84.25M$74.13M$71.87M$48.54M$80.14M$44.84M$63.37M$11.91M$43.59M$39.91M$6.91M$-62,159,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about AVAH

    News

    J.H. Whitney Equity Partners VII sells over $169m in Aveanna stock By Investing.com

    J.H. Whitney Equity Partners VII, a major shareholder in Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH), sold approximately $169.6 million worth of stock through a secondary offering in late August 2026, capitalizing on the stock's near 52-week high. These transactions significantly altered their beneficial ownership in the company. Despite the sales, Aveanna Healthcare reported strong Q2 2026 revenues and raised its full-year outlook, leading to increased price targets from Raymond James and RBC Capital.

    Investing.com South Africa•8/26/26•
    Somewhat-Bullish

    Analysts Offer Insights on Healthcare Companies: Enovis (ENOV) and Aveanna Healthcare Holdings (AVAH)

    BMO Capital analyst Vik Chopra maintained a Buy rating on Enovis (ENOV) with a $30.00 price target, noting a Strong Buy consensus among analysts with a 51.1% upside. Truist Financial analyst David S Macdonald maintained a Hold rating on Aveanna Healthcare Holdings (AVAH) with a $15.00 price target, and the stock currently has a Moderate Buy consensus with a 9.0% upside. Both companies are in the Healthcare sector and have recently received analyst coverage.

    The Globe and Mail•8/25/26•
    Neutral

    Aveanna Healthcare (AVAH) backer sells shares in secondary offering

    J.H. Whitney Equity Partners VII, LLC, a major shareholder in Aveanna Healthcare Holdings, Inc. (AVAH), sold a total of 14,746,077 shares of common stock at $11.50 per share on August 20–21, 2026, through an underwritten secondary offering. After these transactions, J.H. Whitney VII, L.P. and PSA Iliad Holdings LLC reported holding 0 shares. The filing indicates a "Very Negative" sentiment due to the significant insider sale.

    Stock Titan•8/25/26•
    Neutral

    Aveanna to Present at Jefferies Healthcare Services and Technology Conference

    Aveanna Healthcare (NASDAQ: AVAH) announced that its management team will participate in the 2026 Jefferies Healthcare Services and Technology Conference in Nashville on September 15, 2026. The management will present at 4:10 p.m. CST and host 1x1 investor meetings, with a simultaneous webcast available on Aveanna’s investor relations website. This announcement comes after AVAH experienced a 4.1% daily gain, while its peers were mixed.

    Stock Titan•8/25/26•
    Neutral

    Aveanna to Participate in the 2026 Jefferies Healthcare Services and Technology Conference

    Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH) announced that its management team will attend the 2026 Jefferies Healthcare Services and Technology Conference in Nashville on September 15, 2026. Management is scheduled to present at 4:10 PM CST and will also host one-on-one investor meetings. A simultaneous webcast of the presentation will be available on the Investor Relations section of the company's website.

    GlobeNewswire•8/25/26•
    Neutral

    Frequently Asked Questions About AVAH

    Does AVAH pay dividends?
    Aveanna Healthcare Holdings Inc (AVAH) does not currently pay a regular dividend.
    What is AVAH's P/E ratio?
    Aveanna Healthcare Holdings Inc has a price-to-earnings (P/E) ratio of 18.76.
    What is AVAH's market cap?
    Aveanna Healthcare Holdings Inc (AVAH) has a market capitalization of $2.91B with a current stock price of $13.32.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In